drugset / Trial / NCT07556393

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

NCT07556393 ↗

Phase 2 Completed 78 enrolled Inimmune Corporation Rho, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to see how well an experimental nasal spray, called INI-2004, works for those with allergy symptoms to ragweed. This nasal spray will compare how well 500mcg of INI-2004, given once per week for 4 weeks, works at reducing ragweed allergy symptoms in an Environmental Exposure Unit (EEU), compared to placebo.

Timeline

Start
2026-01-19
Primary completion
2026-04-23
Completion
2026-04-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator INI-2004 Unknown 500 ug Intranasal

Indications